Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Advanced Glycation End-product (AGE)-elicited Hepatic Insulin Resistance via Peroxisome Proliferator-activated Receptor-γ Activation

Author: Yoshida T   Yamagishi S   Matsui T   Nakamura K   Ueno T   Takeuchi M   Sata M  

Publisher: Field House Publishing

ISSN: 0300-0605

Source: The Journal of International Medical Research, Vol.36, Iss.2, 2008-03, pp. : 237-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content